VirScan reveals your viral infection history in a single drop of blood

June 4, 2015, Howard Hughes Medical Institute
blood
Credit: Wikimedia Commons

New technology developed by Howard Hughes Medical Institute (HHMI) researchers makes it possible to test for current and past infections with any known human virus by analyzing a single drop of a person's blood. The method, called VirScan, is an efficient alternative to existing diagnostics that test for specific viruses one at a time.

With VirScan, scientists can run a single test to determine which viruses have infected an individual, rather than limiting their analysis to particular viruses. That unbiased approach could uncover unexpected factors affecting individual patients' health, and also expands opportunities to analyze and compare viral infections in large populations. The comprehensive analysis can be performed for about $25 per blood sample.

Stephen Elledge, an HHMI investigator at Brigham and Women's Hospital, led the development of VirScan. "We've developed a screening methodology to basically look back in time in people's [blood] sera and see what viruses they have experienced," he says. "Instead of testing for one individual virus at a time, which is labor intensive, we can assay all of these at once. It's one-stop shopping."

Elledge and his colleagues have already used VirScan to screen the blood of 569 people in the United States, South Africa, Thailand, and Peru. The scientists described the and reported their findings in the June 5, 2015, issue of the journal Science.

VirScan works by screening the blood for antibodies against any of the 206 species of viruses known to infect humans. The immune system ramps up production of pathogen-specific antibodies when it encounters a virus for the first time, and it can continue to produce those antibodies for years or decades after it clears an infection. That means VirScan not only identifies that the immune system is actively fighting, but also provides a history of an individual's past infections.

To develop the new test, Elledge and his colleagues synthesized more than 93,000 short pieces of DNA encoding different segments of . They introduced those pieces of DNA into bacteria-infecting viruses called bacteriophage. Each bacteriophage manufactured one of the protein segments - known as a peptide - and displayed the peptide on its surface. As a group, the bacteriophage displayed all of the protein sequences found in the more than 1,000 known strains of human viruses.

Antibodies in the blood find their viral targets by recognizing unique features known as epitopes that are embedded in proteins on the virus surface. To perform the VirScan analysis, all of the peptide-displaying bacteriophage are allowed to mingle with a blood sample. Antiviral antibodies in the blood find and bind to their target epitopes within the displayed peptides. The scientists then retrieve the antibodies and wash away everything except for the few bacteriophage that cling to them. By sequencing the DNA of those bacteriophage, they can identify which viral protein pieces were grabbed onto by antibodies in the . That tells the scientists which viruses a person's has previously encountered, either through infection or through vaccination. Elledge estimates it would take about 2-3 days to process 100 samples, assuming sequencing is working optimally. He is optimistic the speed of the assay will increase with further development.

To test the method, the team used it to analyze blood samples from patients known to be infected with particular viruses, including HIV and hepatitis C. "It turns out that it works really well," Elledge says. "We were in the sensitivity range of 95 to 100 percent for those, and the specificity was good—we didn't falsely identify people who were negative. That gave us confidence that we could detect other viruses, and when we did see them we would know they were real."

Elledge and his colleagues used VirScan to analyze the antibodies in 569 people from four countries, examining about 100 million potential antibody/epitope interactions. They found that on average, each person had antibodies to ten different species of viruses. As expected, antibodies against certain viruses were common among adults but not in children, suggesting that children had not yet been exposed to those viruses. Individuals residing South Africa, Peru, and Thailand, tended to have antibodies against more viruses than people in the United States. The researchers also found that people infected with HIV had antibodies against many more viruses than did people without HIV.

Elledge says the team was surprised to find that antibody responses against specific were surprisingly similar between individuals, with different people's antibodies recognizing identical amino acids in the viral peptides. "In this paper alone we identified more antibody/peptide interactions to viral proteins than had been identified in the previous history of all viral exploration," he says. The surprising reproducibility of those interactions allowed the team to refine their analysis and improve the sensitivity of VirScan, and Elledge says the method will continue to improve as his team analyzes more samples. Their findings on viral epitopes may also have important implications for vaccine design.

Elledge says the approach his team has developed is not limited to antiviral antibodies. His own lab is also using it to look for antibodies that attack a body's own tissue in certain autoimmune diseases that are associated with cancer. A similar approach could also be used to screen for against other types of pathogens.

Explore further: Finding strengths—and weaknesses—in hepatitis C's armor

More information: Comprehensive serological profiling of human populations using a synthetic human virome, Science, www.sciencemag.org/lookup/doi/ … 1126/science.aaa0698

Related Stories

Finding strengths—and weaknesses—in hepatitis C's armor

March 11, 2015
Using a specially selected library of different hepatitis C viruses, a team of researchers led by Johns Hopkins scientists has identified tiny differences in the pathogens' outer shell proteins that underpin their resistance ...

'Redesigned' antibodies may control HIV

May 18, 2015
With the help of a computer program called "Rosetta," researchers at Vanderbilt University have "redesigned" an antibody that has increased potency and can neutralize more strains of the AIDS-causing human immunodeficiency ...

Cooperation among viral variants helps hepatitis C survive immune system attacks

May 27, 2015
Warring armies use a variety of tactics as they struggle to gain the upper hand. Among their tricks is to attack with a decoy force that occupies the defenders while an unseen force launches a separate attack that the defenders ...

Mining the immune systems of Ebola survivors for therapeutic gold

February 4, 2015
Does the blood of Ebola virus disease survivors contain antibodies and immune cells that could help doctors fight Ebola infections in other people?

Camel, alpaca antibodies target anticancer viruses directly to tumors

February 19, 2015
Using antibodies from camels and alpacas, scientists at Washington University School of Medicine in St. Louis have found a way to deliver anticancer viruses directly to tumor cells, leaving other types of cells uninfected.

Human antibodies target Marburg, Ebola viruses; 1 step closer to vaccine

February 26, 2015
Researchers at Vanderbilt University, the University of Texas Medical Branch at Galveston and The Scripps Research Institute for the first time have shown how human antibodies can neutralize the Marburg virus, a close cousin ...

Recommended for you

3-D bioPen: A hydrogel injection to regenerate cartilage

September 25, 2018
Highly specialized cartilage is characteristically avascular and non-neural in composition with low cell numbers in an aliphatic environment. Despite its apparent simplicity, bioengineering regenerative hyaline cartilage ...

Skin wounds in older mice are less likely to scar

September 25, 2018
Researchers have discovered a rare example in which the mammalian body functions better in old age. A team at the University of Pennsylvania found that, in skin wounds in mice, being older increased tissue regeneration and ...

Study finds that enzymes 'partner up' to accelerate cancer, aging diseases

September 25, 2018
A new study from molecular biologists at Indiana University has identified cellular processes that appear to supercharge both the growth and shrinkage of the chemical "caps" on chromosomes associated with aging, called telomeres.

Extracellular RNA in urine may provide useful biomarkers for muscular dystrophy

September 25, 2018
Massachusetts General Hospital (MGH) researchers have found that extracellular RNA (exRNA) in urine may be a source of biomarkers for the two most common forms of muscular dystrophy, noninvasively providing information about ...

Evidence that addictive behaviors have strong links with ancient retroviral infection

September 24, 2018
New research from an international team led by Oxford University's Department of Zoology and the National-Kapodistrian University of Athens, published today in Proceedings of the National Academy of Sciences (PNAS), shows ...

Taking a catnap? Mouse mutation shown to increase need for sleep

September 24, 2018
Sleep is vital for adequate functioning across the animal kingdom, but little is known about the physiological mechanisms that regulate it, or the reasons for natural variation in people's sleep patterns.

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

machapungo
not rated yet Jun 05, 2015
Could a similar test be created to detect antibodies caused by bacterial pathogens?

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.